AI-Developed Treatment For ALS Patients: Human trials Begin With First Patient Dosed

Artificial intelligence has discovered a life-changing drug, and human trials are underway

ARTIFICIAL Intelligence has found a new drug that could change your life. Human trials have already begun.

The AI-developed treatment developed by the biotech company that made this breakthrough was administered to its first patient.

Alice Zhang is a 33-year-old founder of Verge Genomics. She was formerly a neuroscience doctoral candidate at the University of California.